Use case of artificial intelligence in clinical trial optimisation  

• In: AI as a cost-effectiveness accelerator in drug research and development  on Tuesday, 2 September 2025, 14:30-16:00
• At: Copenhagen (Denmark) (2025)
• Type: Presentation
• By: KUBUSSOVA , Olga
• Abstract:

  Artificial intelligence (AI) is increasingly transforming drug development and clinical trials by enhancing efficiency, reducing costs, and accelerating timelines. Technologies, including machine learning and deep learning, are applied to identify new therapeutic targets, optimise chemical design, and predict protein structures, thereby..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login